PatienTrials vs. VirTrial Participant Utilizzo e statistiche

PatienTrials helps pharma companies and clinicians run global clinical trials virtually, more efficiently in a closed community setting over HIPAA & GDPR compliant collaboration platform. PatienTrials aims to improve patient adherence by empowering participants with information on the progress of treatment at their fingertips in a community setting, that promotes self-care. PatienTrials captures high-quality patient generated data through solutions based on instant messaging, HealthKit, AI and bots, is poised to make a positive impact on drug development. Monitored by proprietary AI agent for adverse events, PatienTrials reduces study risk and lowers development costs. Founded in 2016, PatienTrials is the first company to bring clinical trials on to a HIPAA & GDPR compliant instant messaging platform.
  • App Store di Apple
  • Gratis
  • Settore Medico

Classifica degli store

- -

VirTrial provides convenient access to clinical trials for study participants around the world. The VirTrial Patient application connects study participants to the research site staff for virtual telemedicine visits within a study protocol. The VirTrial app provides a virtual exam room for study participants to see the study staff and physician without the inconvenience of travel to the study site. VirTrial complies with all local, national and global compliance and security requirements
  • App Store di Apple
  • Gratis
  • Settore Medico

Classifica degli store

- -

PatienTrialsRanking a confronto con VirTrial Participant

Confronta la tendenza di classifica PatienTrials nei ultimi 28 giorni rispetto a VirTrial Participant

Rank

Nessun dato disponibile

Classifica PatienTrials vs. VirTrial Participant per paese a confronto

Confronta la tendenza di classifica PatienTrials nei ultimi 28 giorni rispetto a VirTrial Participant

Nessun dato da visualizzare

Fai confronti con qualsiasi sito con la nostra prova gratuita

Inizia
PatienTrials VS.
VirTrial Participant

15icembre d, 2024